FFO
MRNA icon

Fortitude Family Office’s Moderna MRNA Stock Holding History

Fortitude Family Office’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2K Buy
145
+25
+21% +$1.29K ﹤0.01% 762
2026
Q1 		$6.1K Buy
120
+101
+532% +$4.71K ﹤0.01% 849
2025
Q4 		$560 Sell
19
-46
-71% -$1.25K ﹤0.01% 1666
2025
Q3 		$1.68K Hold
65
– – ﹤0.01% 1315
2025
Q2 		$1.79K Buy
+65
New +$1.71K ﹤0.01% 1251
2024
Q4 		– Sell
-124
Closed -$8.29K – 1355
2024
Q3 		$8.29K Buy
124
+96
+343% +$8.81K ﹤0.01% 621
2024
Q2 		$3.33K Buy
28
+22
+367% +$2.78K ﹤0.01% 709
2024
Q1 		$639 Hold
6
– – ﹤0.01% 923
2023
Q4 		$597 Buy
+6
New +$505 ﹤0.01% 972

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Fortitude Family Office's MRNA Position: Q2 2026 in Review

Fortitude Family Office increased its Moderna (MRNA) stake by 21% in Q2 2026, buying an estimated $1.29K and bringing the position to 145 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #762.

Fortitude Family Office first reported a position in MRNA in Q4 2023 and has held it in 9 quarters since. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Fortitude Family Office held 145 shares of Moderna worth $10.2K as of Q2 2026.
  • Fortitude Family Office bought 25 Moderna shares in Q2 2026, an estimated $1.29K.
  • Moderna made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #762 holding.
  • Fortitude Family Office first reported a position in Moderna in Q4 2023 and has held it in 9 quarters since.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.